Prostate cancer: To screen or not to screen? The question is complicated

Cleve Clin J Med. 2021 Jan 1;88(1):17-18. doi: 10.3949/ccjm.88a.20192.

Author

Timothy Gilligan¹

Affiliation

¹ Vice-Chair for Education, Taussig Cancer Institute, Cleveland Clinic; Associate Professor of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH gilligt@ccf.org.

PMID: 33384308
DOI: 10.3949/ccjm.88a.20192

No abstract available

Publication types

Editorial
Comment

MeSH terms

Early Detection of Cancer
Humans
Male
Mass Screening
Prostate-Specific Antigen*
Prostatic Neoplasms* / diagnosis
United Kingdom

Substances

Prostate-Specific Antigen